Pneumotox » Drug » Influenza vaccine

Influenza vaccine

2

See also under 'vaccines'

Last update : 05/02/2021

I.b Pneumonitis (ILD)

1

I.e Acute eosinophilic pneumonia (AEP)

1

I.m ILD with a granulomatous component

1

I.y Progression, acceleration or exacerbation of preexisting ILD/fibrosis

1

II.d Pulmonary edema, cardiogenic

1

III.a Alveolar hemorrhage (AH), diffuse AH (DAH)

1

IV.a Bronchospasm - Wheezing - Asthma

1

X.h Eosinophilic granulomatosis with polyangiitis (Churg-Strauss)

1

X.m Vascultis (pulmonary, extrathoracic or systemic)-ANCA status unknown or negative)

1

X.s Vasculitis, pulmonary (w/wo AH), extrapulmonary, systemic: ANCA-positive

1

X.x Subclinical ANCA positivity

1

XII.d Myocarditis (can be fulminant)

1

XV.e Path: ILD with a granulomatous component (see also Im)

1

XVI.w Imaging: Lung nodule or nodules

1

XVII.a Respiratory tract infection incl. pneumonia

1

Diagnosing DIRD

1

Drug and radiation history

2

Drug singularity - Correct identification of the drug

3

Consistent timing of exposure v. onset of symptoms

4

Clinical, imaging, BAL, pathological pattern consistent with the specific drug

5

Careful exlusion of another cause

6

Remission of symptoms with removal of drug

7

Recurrence with rechallenge (rarely advisable)

8

Causality assessment

More detailed checklist